SCHEDULE: AQR Capital Management Adjusts Exelixis Stake

AQR Capital Management entities report a change in beneficial ownership of Exelixis, Inc. common stock, now holding 4.39% of the class.

Summary

• AQR Capital Management, LLC and AQR Capital Management Holdings, LLC have filed an amended Schedule 13G.
• The filing indicates a change in beneficial ownership of Exelixis, Inc. common stock.
• As of June 30, 2026, the reporting entities collectively beneficially own 11,023,943 shares.
• This represents 4.39% of the class of securities.
• The shares are held with shared voting power and shared dispositive power.
• AQR Capital Management, LLC is a wholly owned subsidiary of AQR Capital Management Holdings, LLC.

Sentiment

Score: 3

Explanation: StockSavvy.ai views this filing as neutral to slightly negative, as it primarily reports a change in beneficial ownership without disclosing specific strategic reasons or significant shifts in investment thesis.

Positives

• The filing clearly states the aggregate amount beneficially owned and the percentage of the class represented, providing transparency.
• The reporting entities confirm that the securities were acquired and are held in the ordinary course of business and not for the purpose of influencing control.

Negatives

• The filing does not provide specific details on the exact nature of the change in beneficial ownership (e.g., increase, decrease, or rebalancing).
• No forward-looking statements or strategic rationale are provided within this filing.

Risks

• The filing does not explicitly mention any new or evolving risks related to Exelixis, Inc. or the investment itself.

Future Outlook

No forward-looking statements or guidance are provided in this filing.

Management Comments

• "By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under 240.14a-11."
• "After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct."

Industry Context

StockSavvy.ai notes that Schedule 13G filings are routine disclosures for institutional investors crossing certain ownership thresholds. This filing by AQR Capital Management indicates a significant, but not controlling, stake in Exelixis, Inc., a biotechnology company.

Stakeholder Impact

• Shareholders: Provides transparency on a significant institutional investor's holdings, which can influence market perception.
• Management of Exelixis, Inc.: May be aware of increased institutional interest or potential shifts in shareholder base.

Next Steps

• Continue to monitor future SEC filings from AQR Capital Management for any further changes in beneficial ownership or strategic actions.
• Observe Exelixis, Inc.'s performance and strategic developments for insights into the investment's rationale.

Key Dates

Keywords

Exelixis, AQR Capital Management, Schedule 13G, Beneficial Ownership, Common Stock, Investment Management, SEC Filing